+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Resorbable Vascular Scaffold Market by Indication, Material, End User, Distribution Channel, Scaffold Diameter, Scaffold Length - Global Forecast to 2030- Product Image
Resorbable Vascular Scaffold Market by Indication, Material, End User, Distribution Channel, Scaffold Diameter, Scaffold Length - Global Forecast to 2030- Product Image
Sale

Resorbable Vascular Scaffold Market by Indication, Material, End User, Distribution Channel, Scaffold Diameter, Scaffold Length - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012364
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The resorbable vascular scaffold market is undergoing a dynamic transformation, driven by the integration of innovative materials and evolving procedural standards. Senior executives are seeking advanced, patient-centric solutions that minimize long-term complications while aligning with changing regulatory and operational environments.

Market Snapshot: Resorbable Vascular Scaffold Market Growth & Prospects

The resorbable vascular scaffold market grew from USD 576.57 million in 2024 to USD 656.95 million in 2025. It is poised to sustain robust momentum at a CAGR of 13.82%, projected to reach USD 1.25 billion by 2030. This trajectory reflects accelerating adoption in minimally invasive cardiology and vascular procedures, with escalating investments in R&D and supply chain recalibration among key factors shaping future performance.

Scope & Segmentation

This report delivers comprehensive granularity across multiple dimensions to facilitate strategic planning:

  • Indication:
    • Coronary artery disease (including acute coronary syndrome, stable angina)
    • Peripheral arterial disease (claudication, critical limb ischemia)
  • Material:
    • Magnesium
    • Polylactic acid
  • End User:
    • Ambulatory surgical centers
    • Cardiac centers
    • Hospitals
  • Distribution Channel:
    • Direct sales
    • Distributor
  • Scaffold Diameter:
    • Less than 3 millimeter
    • Three millimeter and above
  • Scaffold Length:
    • Eighteen to twenty-eight millimeter
    • Greater than twenty-eight millimeter
    • Less than eighteen millimeter
  • Region:
    • Americas (including United States, Canada, Mexico, Brazil, Argentina)
    • Europe, Middle East & Africa (Western and emerging markets)
    • Asia-Pacific (key countries across East and Southeast Asia)
  • Key Companies:
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • Terumo Corporation
    • Meril Life Sciences Private Limited
    • Elixir Medical Corporation
    • Xeltis AG
    • Amaran Cardiovascular LLC
    • Cardionovum GmbH
    • MicroPort Scientific Corporation

Key Takeaways

  • Shifting clinical practice patterns favor temporary, resorbable technologies for cardiovascular and peripheral interventions, reflecting growing clinician confidence and regulatory alignment.
  • Innovations in polymer and magnesium alloys enable tailored absorption rates and improved vessel healing, amplifying the value proposition for next-generation scaffolds.
  • Next-generation imaging tools and digital health platforms enhance scaffold monitoring and patient outcome tracking, supporting robust post-market surveillance by providers and manufacturers.
  • Procurement models are being adapted to ensure stable pricing, with strategic supplier partnerships becoming essential in navigating supply chain pressures.
  • Distinct adoption curves exist across high-volume cardiac centers, outpatient suites, and emerging hospital settings, requiring nuanced go-to-market and educational strategies.
  • Strong collaboration between device innovators and academic centers is accelerating evidence generation, bolstering clinical acceptance and differentiation in a competitive landscape.

Tariff Impact: Navigating Supply Chain Challenges

Recent tariffs on imported components and materials in the United States for 2025 are catalyzing a reassessment of sourcing and supply chain management within the resorbable vascular scaffold segment. Leading manufacturers are pursuing nearshoring and forming regional supplier partnerships to offset new cost pressures and support uninterrupted access. For providers, these dynamics highlight the need for agile procurement strategies—such as long-term contracts and group purchasing consortia—to maintain cost efficiency and reliable supply of advanced scaffold solutions.

Methodology & Data Sources

Research findings are synthesized from extensive primary interviews with subject matter experts— including interventional cardiologists, vascular surgeons, and procurement executives—alongside in-depth secondary analysis of peer-reviewed publications, regulatory filings, and corporate disclosures. Quantitative and qualitative insights are cross-validated through a multi-step process, guaranteeing reliability and transparency throughout.

Why This Report Matters

  • Supports executive decision-making by clarifying evolving technology trends and regional market differences in resorbable vascular scaffolds.
  • Highlights actionable opportunities to optimize products, partnerships, and supply strategies amid macroeconomic and policy changes.
  • Equips stakeholders to proactively address risk, regulatory shifts, and future growth drivers in interventional vascular therapies.

Conclusion

The resorbable vascular scaffold market is positioned for ongoing innovation and expansion, shaped by technological progress and shifting global care standards. This report enables leaders to identify, evaluate, and leverage emerging opportunities for sustainable, competitive growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Resorbable Vascular Scaffold Market, by Indication
8.1. Introduction
8.2. Coronary Artery Disease
8.2.1. Acute Coronary Syndrome
8.2.2. Stable Angina
8.3. Peripheral Arterial Disease
8.3.1. Claudication
8.3.2. Critical Limb Ischemia
9. Resorbable Vascular Scaffold Market, by Material
9.1. Introduction
9.2. Magnesium
9.3. Polylactic Acid
10. Resorbable Vascular Scaffold Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cardiac Centers
10.4. Hospitals
11. Resorbable Vascular Scaffold Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor
12. Resorbable Vascular Scaffold Market, by Scaffold Diameter
12.1. Introduction
12.2. Less Than 3 Millimeter
12.3. Three Millimeter And Above
13. Resorbable Vascular Scaffold Market, by Scaffold Length
13.1. Introduction
13.2. Eighteen To Twenty Eight Millimeter
13.3. Greater Than Twenty Eight Millimeter
13.4. Less Than Eighteen Millimeter
14. Americas Resorbable Vascular Scaffold Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Resorbable Vascular Scaffold Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Resorbable Vascular Scaffold Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Boston Scientific Corporation
17.3.3. Biotronik SE & Co. KG
17.3.4. Terumo Corporation
17.3.5. Meril Life Sciences Private Limited
17.3.6. Elixir Medical Corporation
17.3.7. Xeltis AG
17.3.8. Amaran Cardiovascular LLC
17.3.9. Cardionovum GmbH
17.3.10. MicroPort Scientific Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. RESORBABLE VASCULAR SCAFFOLD MARKET MULTI-CURRENCY
FIGURE 2. RESORBABLE VASCULAR SCAFFOLD MARKET MULTI-LANGUAGE
FIGURE 3. RESORBABLE VASCULAR SCAFFOLD MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RESORBABLE VASCULAR SCAFFOLD MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 53. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 57. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 58. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 62. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 99. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 103. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 106. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 107. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 111. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 123. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 125. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 126. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 127. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 130. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 131. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 135. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 138. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 147. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 155. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 163. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 167. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 170. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 179. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 181. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 182. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 183. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 186. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 187. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 194. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 195. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 211. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 215. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 219. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 223. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 226. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 235. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 237. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 239. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 243. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 245. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 246. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 247. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 250. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 269. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 270. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 271. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 272. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 275. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 276. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 278. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 279. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 280. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 283. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 284. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 285. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 286. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 288. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Resorbable Vascular Scaffold market report include:
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Meril Life Sciences Private Limited
  • Elixir Medical Corporation
  • Xeltis AG
  • Amaran Cardiovascular LLC
  • Cardionovum GmbH
  • MicroPort Scientific Corporation

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 656.95 Million
Forecasted Market Value ( USD ) by 2030 $ 1250 Million
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Resorbable Vascular Scaffolds Global Market Report 2025 - Product Image

Resorbable Vascular Scaffolds Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 195 Pages
  • Global
From
Bioresorbable Vascular Scaffolds - Global Strategic Business Report - Product Image

Bioresorbable Vascular Scaffolds - Global Strategic Business Report

  • Report
  • 265 Pages
  • Global
From
Peripheral Vascular Devices Industry, Global, 2024-2029 - Product Image

Peripheral Vascular Devices Industry, Global, 2024-2029

  • Report
  • Global
From
Cardiovascular Repair & Reconstruction Devices Market by Product Type, Technology, Application, End User, Material - Global Forecast to 2030 - Product Image

Cardiovascular Repair & Reconstruction Devices Market by Product Type, Technology, Application, End User, Material - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From

About the Market

The Resorbable Vascular Scaffold (RVS) market is a segment of the Cardiovascular Devices industry. RVS are medical devices used to treat coronary artery disease, a condition caused by the narrowing of the arteries that supply blood to the heart. RVS are designed to be implanted in the artery and gradually dissolve over time, allowing the artery to return to its natural state. This technology has been shown to reduce the risk of restenosis, a condition in which the artery becomes narrowed again after treatment. RVS are becoming increasingly popular due to their ability to reduce the risk of restenosis and the fact that they do not require a second procedure to remove the device. Additionally, RVS are less invasive than traditional stents, which require a larger incision and a longer recovery time. Some companies in the RVS market include Abbott, Biotronik, Boston Scientific, Medtronic, and Terumo. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.